{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:03Z","timestamp":1793325663193,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,11]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Ankylosing spondylitis (AS) is a type of autoimmune disease commonly characterized by joint pain and stiffness. This disease progression can exhibit common deformities and other activities with limited symptoms and significantly impacts people\u2019s work and life. Electroacupuncture (EA) as a traditional Chinese therapy, showing several advantages (e.g., safety, economy, and less side effects), has been extensively used to treat AS. However, its curative effect is supported by limited evidence. Accordingly, the present study aims to comprehensively assess the reliability of EA in AS treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>The study will conduct a systematic review and meta-analysis. Seven databases, including the Embase, Cochrane Library, Pubmed, SinoMed, CNKI, VIP, and Wanfang Data, will be searched using predefined search terms to identify relevant studies. The primary outcomes will be the clinical efficiency, the Bath AS Disease Activity Index, and the Visual Analog Scale. Eligible studies should report at least 1 of these primary outcomes. Eligible studies designed as randomized controlled trials will be included for meta-analysis, while other related clinical studies will be reviewed. The methodological quality of the included studies will be assessed with a previously established checklist. The Cochrane Collaboration\u2019s bias risk tool will be used for assessing the bias of included randomized controlled trials. Stata 17.0 software is used for meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The protocol will be used to assess the efficacy and safety of EA in AS treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This review reliably evidences whether EA is a reliable method for the intervention of AS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031706","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T14:06:44Z","timestamp":1668694004000},"page":"e31706","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and safety of electroacupuncture for ankylosing spondylitis: A protocol for a systematic reviews and meta-analysis"],"prefix":"10.1097","volume":"101","author":[{"given":"Shenghui","family":"Liu","sequence":"first","affiliation":[{"name":"Jiujiang First People\u2019s Hospital Rheumatology Department, Jiujiang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-7362","authenticated-orcid":false,"given":"Jiangxia","family":"Zheng","sequence":"additional","affiliation":[{"name":"Jiujiang First People\u2019s Hospital Rheumatology Department, Jiujiang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Wen","sequence":"additional","affiliation":[{"name":"Jiujiang First People\u2019s Hospital Rheumatology Department, Jiujiang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Fang","sequence":"additional","affiliation":[{"name":"Jiujiang First People\u2019s Hospital Rheumatology Department, Jiujiang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jiujiang First People\u2019s Hospital Rheumatology Department, Jiujiang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R2-20250504","first-page":"CD011321","article-title":"Exercise programmes for ankylosing spondylitis","volume":"10","author":"Regnaux","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R3-20250504","first-page":"4","article-title":"The burden of ankylosing spondylitis","volume":"78","author":"Boonen","year":"2006","journal-title":"J Rheumatol Suppl"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.rdc.2020.01.012","article-title":"The patient\u2019s perspective on the burden of disease in ankylosing spondylitis","volume":"46","author":"See","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00296-020-04537-0","article-title":"Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis","volume":"40","author":"Zhao","year":"2020","journal-title":"Rheumatol Int"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"R7-20250504","first-page":"1649","article-title":"Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men","volume":"17","author":"Will","year":"1990","journal-title":"J Rheumatol"},{"key":"R8-20250504","first-page":"947","article-title":"Does male:female sex ratio in ankylosing spondylitis change with age?","volume":"23","author":"Masi","year":"1996","journal-title":"J Rheumatol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/papt.12016","article-title":"Body image disturbance and quality of life in Chinese patients with ankylosing spondylitis","volume":"87","author":"Shen","year":"2014","journal-title":"Psychol Psychother"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1759720X20949088","DOI":"10.1177\/1759720X20949088","article-title":"Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"12","author":"Tektonidou","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MAJ.0b013e3182514093","article-title":"Economic considerations of the treatment of ankylosing spondylitis","volume":"343","author":"Reveille","year":"2012","journal-title":"Am J Med Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/ard.2009.116764","article-title":"Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost","volume":"69","author":"Boonen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/annrheumdis-2012-201844","article-title":"NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms?","volume":"71","author":"Haroon","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1136\/annrheumdis-2015-207978","article-title":"Immunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatment","volume":"74","author":"Chen","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 3","key":"R15-20250504","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1136\/ard.61.suppl_3.iii40","article-title":"Conventional treatments for ankylosing spondylitis","volume":"61","author":"Dougados","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cpt.1830","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs","volume":"108","author":"Theken","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.gastrohep.2021.06.003","article-title":"NSAIDs, gastrointestinal toxicity and inflammatory bowel disease","volume":"45","author":"Hijos-Mallada","year":"2022","journal-title":"Gastroenterol Hepatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3899\/jrheum.200265","article-title":"The risk of cardiovascular events associated with disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"48","author":"Ozen","year":"2021","journal-title":"J Rheumatol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2174\/138161212799504759","article-title":"Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research","volume":"18","author":"Gasparyan","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-159-4-201308200-00006","article-title":"Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial","volume":"159","author":"Kremer","year":"2013","journal-title":"Ann Intern Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000327911","article-title":"Anti-inflammatory effects of electroacupuncture in the respiratory system of a symptomatic amyotrophic lateral sclerosis animal model","volume":"8","author":"Jiang","year":"2011","journal-title":"Neurodegener Dis"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainresbull.2009.04.020","article-title":"Electroacupuncture downregulates TLR2\/4 and pro-inflammatory cytokine expression after surgical trauma stress without adrenal glands involvement","volume":"80","author":"Wang","year":"2009","journal-title":"Brain Res Bull"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.joim.2018.10.003","article-title":"Electro-acupuncture regulates the cholinergic anti-inflammatory pathway in a rat model of chronic obstructive pulmonary disease","volume":"16","author":"Zhang","year":"2018","journal-title":"J Integr Med"},{"key":"R24-20250504","first-page":"893","article-title":"Clinical review of ankylosing spondylitis treated with acupuncture and medicine","volume":"36","author":"Zhang","year":"2016","journal-title":"Zhongguo Zhen Jiu"},{"key":"R25-20250504","first-page":"248","article-title":"Therapieeffekt der Intrathekal-, Nervenstamm- und Druckschmerzpunktelektroakupunktur bei hartn\u00e4ckigen, heftigen Kreuz- und Beinschmerzen [Therapy effect of intrathecal, nerve stem and pain pressure point electroacupuncture in severe refractory back and leg pains]","volume":"4","author":"Liu","year":"1984","journal-title":"Acta Acad Med Wuhan"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:02:26Z","timestamp":1746334946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":27,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031706","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}